Search
Stifel's Paul Matteis joins BiotechTV for Analyst Thursdays
- blonca9
- Nov 9, 2023
- 1 min read
Paul Matteis comments on Biogen and Vertex earnings, discusses recent news on BioMarin and Sage, and highlights Xenon, Neumora, Karuna, Cerevel, and others.